Abstract | BACKGROUND: OBJECTIVES: To identify factors that contribute to plasmid-independent metronidazole resistance of C. difficile. METHODS: Here, we investigate resistance to metronidazole in a collection of clinical isolates of C. difficile using a combination of antimicrobial susceptibility testing on different solid agar media and WGS of selected isolates. RESULTS: We find that nearly all isolates demonstrate a haem-dependent increase in the MIC of metronidazole, which in some cases leads to isolates qualifying as resistant (MIC >2 mg/L). Moreover, we find an SNP in the haem-responsive gene hsmA, which defines a metronidazole-resistant lineage of PCR ribotype 010/MLST ST15 isolates that also includes pCD-METRO-containing strains. CONCLUSIONS: Our data demonstrate that haem is crucial for medium-dependent metronidazole resistance in C. difficile.
|
Authors | Ilse M Boekhoud, Igor Sidorov, Sam Nooij, Céline Harmanus, Ingrid M J G Bos-Sanders, Virginie Viprey, William Spittal, Emma Clark, Kerrie Davies, Jane Freeman, Ed J Kuijper, Wiep Klaas Smits, COMBACTE-CDI Consortium |
Journal | The Journal of antimicrobial chemotherapy
(J Antimicrob Chemother)
Vol. 76
Issue 7
Pg. 1731-1740
(06 18 2021)
ISSN: 1460-2091 [Electronic] England |
PMID | 33876817
(Publication Type: Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
|
Copyright | © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. |
Chemical References |
- Anti-Bacterial Agents
- Metronidazole
- Heme
|
Topics |
- Anti-Bacterial Agents
(pharmacology, therapeutic use)
- Clostridioides
- Clostridioides difficile
(genetics)
- Clostridium Infections
(drug therapy)
- Heme
- Humans
- Metronidazole
(pharmacology)
- Microbial Sensitivity Tests
- Multilocus Sequence Typing
- Ribotyping
|